Articles with "prevention trials" as a keyword



Photo by nci from unsplash

Strengthening stakeholder engagement through ethics review in biomedical HIV prevention trials: opportunities and complexities

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of the International AIDS Society"

DOI: 10.1002/jia2.25172

Abstract: Clinical trials of biomedical HIV prevention modalities require the cooperation of multiple stakeholders. Key stakeholders, such as community members, may have stark vulnerabilities. Consequently, calls for HIV prevention researchers to implement “stakeholder engagement” are increasingly… read more here.

Keywords: hiv prevention; ethics review; prevention trials; stakeholder engagement ... See more keywords
Photo from wikipedia

The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset

Sign Up to like & get
recommendations!
Published in 2018 at "Expert Opinion on Biological Therapy"

DOI: 10.1080/14712598.2018.1389885

Abstract: ABSTRACT Introduction: The recent failure of several clinical trials on anti-β-amyloid (Aβ) drugs in Alzheimer’s disease (AD) suggested earlier intervention in the disease course. Secondary prevention trials have been started in autosomal-dominant AD (ADAD) individuals… read more here.

Keywords: alzheimer disease; solanezumab gantenerumab; disease; prevention trials ... See more keywords
Photo from wikipedia

Viral Genetic Linkage Analysis Among Black Men Who Have Sex With Men (HIV Prevention Trials Network 061)

Sign Up to like & get
recommendations!
Published in 2019 at "AIDS Research and Human Retroviruses"

DOI: 10.1089/aid.2018.0204

Abstract: Abstract Analysis of viral genetic linkage can reveal generalized transmission patterns within a population. The HIV Prevention Trials Network 061 study evaluated HIV incidence among black men who ... read more here.

Keywords: hiv prevention; viral genetic; prevention trials; trials network ... See more keywords
Photo by cdc from unsplash

Incidence and Correlates of Sexually Transmitted Infections Among Black Men Who Have Sex With Men Participating in the HIV Prevention Trials Network 073 Preexposure Prophylaxis Study

Sign Up to like & get
recommendations!
Published in 2019 at "Clinical Infectious Diseases"

DOI: 10.1093/cid/ciy1141

Abstract: The HIV Prevention Trials Network (HPTN) Study 073 (HPTN 073) assessed the feasibility, acceptability, and safety of preexposure prophylaxis (PrEP) for black men who have sex with men (BMSM). The purpose of this analysis was… read more here.

Keywords: hiv; incidence; prevention trials; hiv prevention ... See more keywords
Photo from wikipedia

Characteristics Associated With Human Immunodeficiency Virus Transmission Networks Involving Adolescent Girls and Young Women in Human Immunodeficiency Virus Prevention Trials Network 068 Study.

Sign Up to like & get
recommendations!
Published in 2019 at "Sexually transmitted diseases"

DOI: 10.1097/olq.0000000000000954

Abstract: We combined behavioral survey data from the human immunodeficiency virus (HIV) Prevention Trials Network 068 study with phylogenetic information to determine if cluster membership was associated with characteristics of young women and their partners. Clusters… read more here.

Keywords: young women; immunodeficiency virus; human immunodeficiency; prevention trials ... See more keywords
Photo from wikipedia

Core outcomes for pressure ulcer prevention trials: results of an international consensus study

Sign Up to like & get
recommendations!
Published in 2022 at "British Journal of Dermatology"

DOI: 10.1111/bjd.21741

Abstract: There is substantial heterogeneity between trial outcomes in pressure ulcer prevention research. The development of core outcome sets is one strategy to improve comparability between trial results and thus increase the quality of evidence. read more here.

Keywords: ulcer prevention; prevention trials; pressure ulcer; core outcomes ... See more keywords
Photo from wikipedia

Evaluating group-sequential non-inferiority clinical trials following interim stopping: The HIV Prevention Trials Network 083 trial

Sign Up to like & get
recommendations!
Published in 2022 at "Clinical Trials"

DOI: 10.1177/17407745221118371

Abstract: Background/Aims: The HIV Prevention Trials Network 083 trial was a group-sequential non-inferiority trial designed to compare HIV incidence under a novel experimental regimen for HIV prevention, long-acting injectable cabotegravir, with an active-control regimen of daily… read more here.

Keywords: hiv prevention; prevention trials; network 083; trials network ... See more keywords
Photo from wikipedia

“Spatial heterogeneity of environmental risk in randomized prevention trials: consequences and modeling”

Sign Up to like & get
recommendations!
Published in 2019 at "BMC Medical Research Methodology"

DOI: 10.1186/s12874-019-0759-z

Abstract: BackgroundIn the context of environmentally influenced communicable diseases, proximity to environmental sources results in spatial heterogeneity of risk, which is sometimes difficult to measure in the field. Most prevention trials use randomization to achieve comparability… read more here.

Keywords: risk; randomized prevention; heterogeneity; prevention trials ... See more keywords
Photo by nci from unsplash

Barriers to Screening: An Analysis of Factors Impacting Screening for Type 1 Diabetes Prevention Trials

Sign Up to like & get
recommendations!
Published in 2023 at "Journal of the Endocrine Society"

DOI: 10.1210/jendso/bvad003

Abstract: Abstract Context Participants with stage 1 or 2 type 1 diabetes (T1D) qualify for prevention trials, but factors involved in screening for such trials are largely unknown. Objective To identify factors associated with screening for… read more here.

Keywords: prevention trials; prevention; prevention trial; type diabetes ... See more keywords
Photo from wikipedia

What to Test in Parkinson Disease Prevention Trials? Repurposed, Low-Risk, and Gene-Targeted Drugs.

Sign Up to like & get
recommendations!
Published in 2022 at "Neurology"

DOI: 10.1212/wnl.0000000000200238

Abstract: Despite the sound epidemiologic and basic science rationales underpinning numerous "disease modification" trials in manifest Parkinson disease (PD), none has convincingly demonstrated that a treatment slows progression. Rapidly expanding knowledge of the genetic determinants and… read more here.

Keywords: prevention trials; prevention; parkinson disease; risk ... See more keywords
Photo from wikipedia

Planning for Prevention of Parkinson Disease

Sign Up to like & get
recommendations!
Published in 2022 at "Neurology"

DOI: 10.1212/wnl.0000000000200789

Abstract: Parkinson disease (PD) is a chronic progressive neurodegenerative disease with increasing worldwide prevalence. Despite many trials of neuroprotective therapies in manifest PD, no disease-modifying therapy has been established. Over the past several decades, a series… read more here.

Keywords: prevention trials; prevention; disease; parkinson disease ... See more keywords